News
By Min Joo Kang Nominal labour cash earnings grew slower than expected in August We had expected to see some acceleration in earnings given...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
News
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
News
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
News
Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both...
News
Over the past few months, I have reviewed several funds from Simplify Asset Management. Some have been hits like the Simplify Volatility Premium ETF...
News
US This week will deliver a make-or-break moment for Fed rate hike expectations. The main event will be the September inflation report. Expectations are...
News
Topline Summary Nurix Therapeutics (NASDAQ:NRIX) is a biotech company specializing in the development of protein degraders, which are intended as a new class of...
News
I’m writing this from Portugal this week – as we had a trip planned months ago to visit Lisbon, Algarve and Sintra. Being in...
News
For more than 40 million people, the bill is due, again. After more than a three-year hiatus, those who are part of the more...
News
The most recent U.S. jobs data suggests the employment sector may be showing signs of cooling. Rannella Billy-Ochieng’, Senior Economist at TD, speaks with...
News
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) is a good speculative biotech play to look into. That’s because it expects to present preliminary results from an...
News
The impulse to travel is one of the hopeful symptoms of life.” ― Agnes Repplier. Today, we take a look at a firm that...
